| NCT Number | NCT07225790 |
| Lead Sponsor | Brigham and Women's Hospital
Collaborators: Food and Drug Administration (FDA) |
| Conditions | Advanced Breast Cancer |
| Enrollment | 3,883 participants |
| Start Date | 2025-11-03 |
| Primary Completion | 2026-01-31 (estimated) |
| Study Completion | 2026-01-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-12 |